These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Weighing community and individual needs: clinical testing. Rosenberg LT. Health Care Women Int; 1993; 14(1):1-5. PubMed ID: 8454522 [No Abstract] [Full Text] [Related]
47. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Czeizel AE. Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):260-8. PubMed ID: 19161162 [Abstract] [Full Text] [Related]
48. Prevention of NTDs with periconceptional multivitamin supplementation containing folic acid in China. Chen G, Song X, Ji Y, Zhang L, Pei L, Chen J, Liu J, Li C, Zheng X. Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):592-6. PubMed ID: 18634013 [Abstract] [Full Text] [Related]
49. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification. Bower C, D'Antoine H, Stanley FJ. Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):269-73. PubMed ID: 19180646 [Abstract] [Full Text] [Related]
59. Economic evaluation of a neural tube defect recurrence-prevention program. Grosse SD, Ouyang L, Collins JS, Green D, Dean JH, Stevenson RE. Am J Prev Med; 2008 Dec 17; 35(6):572-7. PubMed ID: 18845415 [Abstract] [Full Text] [Related]
60. Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants. Harris MJ. Birth Defects Res A Clin Mol Teratol; 2009 Apr 17; 85(4):331-9. PubMed ID: 19117321 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]